ARCHIVES

Duke Retraction May Alter IOM Investigation; Review Panel Membership Announced

This article is from The Cancer Letter archive.

Vol. 36 No. 40 | November 5, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves Velcade Injection In Mantle Cell Lymphoma

October 31, 2014

President’s Cancer Panel urges comprehensive health care reform, provision of services for cancer survivors.

June 4, 2004

It’s “High Noon” For Cancer, Vice President Says

October 2, 1998

No Benefit To Shark Cartilage As Treatment, Large Trial Finds

July 27, 2007

House committee asks GAO to investigate Klausner-era NCI contract with Harvard University.

September 9, 2005

Stereo Mammography Detects More Lesions, Study Finds

December 28, 2007